New shot for babies aims to block dangerous RSV virus
NCT ID NCT07363837
Summary
This study is testing a new injection called SIBP-A16 to see if it can help prevent serious illness from Respiratory Syncytial Virus (RSV) in infants. It will involve 36 premature and full-term babies under 1 year old who are entering their first RSV season. Researchers will give different doses to small groups to check for safety and to see how the babies' bodies respond and make protective antibodies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Second Hospital, Sichuan University
Chengdu, Sichuan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.